• Menu

  • Nexalin Technology

    • History

    Kalaco was formed in November 2001 and immediately began efforts to raise the money necessary to bring the Nexalin® Technology to the world market in a manner that is atypical for a medical device manufacturing company. The importance of the technology demands this advanced business approach. The Nexalin Technology is an evolution of 25+ years of research.

    Kalaco currently has clearance in the United States for Anxiety, Depression, and Insomnia. Other intended uses are approved in other countries, but not yet in the United States and require investigation and FDA market authorization before the Nexalin™ technology can be offered for those uses.


    All contents © copyright 2009 Kalaco Scientific, Inc. All Rights reserved.